Coordinating Cancer and HIV Research

Generalized anxiety disorder is associated with lower rates of HIV treatment, adherence to treatment and viral suppression.

Meet the real people of color behind Houston’s effort to educate about PrEP and TasP.

A new analysis of the global START trial found that health outcomes were better for those starting treatment within six months.

A look at what the law says about buying prescription drugs from Canada.

After almost a decade on antiretroviral therapy, half of study participants still had HIV in immune cells in their brain and spinal fluid.

Investigators led by Scripps Research will study vaccines that coax the immune system into creating antibodies that protect against HIV.

Electronic prompts for clinicians to recommend Truvada to people at risk for HIV could help increase PrEP’s impact.

Researchers compared outcomes between babies born to HIV-positive mothers exposed to antiretrovirals and those who were not.